{"id":999801,"date":"2026-09-02T09:05:14","date_gmt":"2026-09-02T13:05:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/"},"modified":"2026-09-02T09:05:14","modified_gmt":"2026-09-02T13:05:14","slug":"annexon-to-participate-in-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/","title":{"rendered":"Annexon to Participate in Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BRISBANE, Calif., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Qh8nvLMLqsMvuENk4zC8rF38WV0BB4ANEU3iDAC6_lvAxK99cikghLcQZm-Zpx-f865dPlAoUVEny1-zd1X5TwtWdT6iSooImJG2kvcVSyeoWS5FLve_BVMpAAY-3xi0igpeVhJGmPUcVLIk94WChNmdqnvMBEMgHzFvz2_8HvcZDhzckZFIj6eCHyWH99ypNsos91jtTfsjCbxaOJR7w13TlG0ep5bbowPsMsmSyMg=\" rel=\"nofollow\" target=\"_blank\">Annexon, Inc.<\/a>\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following September investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. ET in Boston, MA; and,<\/li>\n<li style=\"margin-bottom:8pt\">Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 1:35 p.m. ET in New York, NY; and,<\/li>\n<li style=\"margin-bottom:8pt\">H.C. Wainwright 28<sup>th<\/sup> Annual Global Investment Conference on Tuesday, September 15, 2026, at 1:00 p.m. ET in New York, NY.<\/li>\n<\/ul>\n<p>Live webcasts of the presentations can be accessed under the \u2018Events &amp; Presentations\u2019 section on the Investors page at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IOZEsV68VNe5r3hf1Oqi9eI6sYGJeWXkN16Dgbdw4ODkdC7hnm8wfVK8HRk1Ovqszsh5No7dY-YVI1VzXET3Bz6Mn_xvHk_g3KPjRPIl7zSNl_Lvu8NdJvnMNNs5bOxvw0UV0ot4mO6jszraFDsC9Xr490TCXIy5fVlHUY_1W_-pJop5XfWWH0yXJMiJ76lOfwphBKgQRam16KHL6GDRpeGtFmA2kyAuf9eHa5cm9i1i0JJZGnsKwpFv4EKooch5W1pagJ-9R8vdFgn_untd0lrRkO1aLIHmGV-P2EVRv-HIaLtao8mF89t374cokURtbOe5s2CGvEjbflsFTcDaMP6og4VmNNujRllqYjo_6EftJPPSguhdVrb81MhrKe3UuoaY1TbX3n15fumJ1WZYdOssjzsBwujvbvVdsjtYvNA=\" rel=\"nofollow\" target=\"_blank\">annexonbio.com<\/a>. Replays of the webcasts will be archived on the Annexon website for 30 days following the presentations.<\/p>\n<p>\n        <strong>About Annexon<\/strong>\n      <\/p>\n<p>Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million people worldwide living with serious neuroinflammatory diseases. Our founding scientific approach focuses on C1q, the initiating molecule of a potent inflammatory pathway that when misdirected can lead to tissue damage and loss of function in a host of diseases. Our targeted therapies are designed to stop classical complement-driven neuroinflammation at its source to provide meaningful functional benefit and alter the course of disease. Annexon\u2019s mission is to deliver game-changing therapies to patients so that they can live their best lives. To learn more visit annexonbio.com.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FYr3-BmqUfH7YkeNf68HJYRchv4RQ6Uo1jdrxEdddb7W33wLW1WtcOTNP4z7Q0ENF8B7gohocud4pXDu7UnceVcC8eIucq8hS09rWM4dib9FnC0QLvgOfCEnWDRGkC4O-rXZ615Q9ygT-HR4pjfw4dr4KsOdx53luAuzrThhAeYNPSXx5UTNsXRczaYq8t02WB4hGntityVVvmJ0z6m_imrYzdl2F_voZVHbObGgPb_sDL-iR-Oo1pCAePTY9iufFMfpJlXG6VaXQZ5ENkH514O4dIt8u8JY-n_Cstyd-Wa6Jfth0ag1vfRbVTwXMKE17wgoj2ArxKJTZ-l9YuIINL3ljNDV9DPgebXvf59pYcH409SNNmxFd1nQiWuR6ZvMcs0VB6SSxyuOnowuhJyW9oH29FOwwwilEhTzzTvlManQVtPe1UHy895cNP6WjCbWkF_WTosv2m0WmkfhheWNLea4l5N9FIXJ_3bqPuRY8KvbBXp7Ix_dk2TRmqlNTIseMHSX9M8XC9WodU5c7kJx4TAJv_mzA0AtkxxIJMGeXE2Xxkzcy2gncP65LexOOnHF\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Beth Keshishian<br \/>917-912-7195<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UkfXbxhCENx_LIcjD96l64U9zRlZtUZu0a7sm_OzDKR1CyJI2qWjx9CQbJovq9D04qmpnrqaft39fpvIbtQStW9iYogWkYl6NfDA_MhfQOZX5Wdv5DA--6Ny2JpwP_OMA1tVG1QRrChXHNgPdH_rU7tQwGrMTMtZkcysm9tIwZKzgWHXyC6taqqU7p-1xt5zpaGVDL9OFEVrcNg3lxk410G-1reaN4BorJ1A2ZdxC0WGHRzDRkbpwH8ugLFBrWF9HY-WkS-QJ5suSlst3lHBanqvjxN9eA0zKtOpiWVQBc4VgKVwCJ2no_yLGomSdEY2iBXjVPbRxRlgpfcZG6Q1VZl1YrZan1trMIfK8Lqgc6zEDjNHnY7y9loFC5qaNXZARAJrA-ktdUvEvXQkTf0iN4YQFsrwjoBp7LJgYfnOIuJFkNgS42MoqsTPIxjCaN0MDoPtqT0iG-OQ8d6X0HO_yMX3Ht2wfiSd-57u3FSR7kw9ioPNihu-aCh6JWZkBzzppcwlBS8JkT3fK-YnbdzbYRBogM6ddtJf5fYulNXG_zmH-sjdqQAGgMDNp1_P7QaQxdMS8hLuNPs5FNW4ekbRtIEcQasxjmL1w33Rcytieag7khuhje1J4UVCfQhNHQvY9hLAAysX2KFjAUIvxQA5t-y0Tcx_T89cggOzx6CdioNo0guVdQBIPEmjvltwOVTSuLJiTS9hYHVZvqoL5AND3amnjrsey5DXjFYmzNCu93Zqpxr2bjIoc7x7Ek5HQkpfnKZgOTZZOU42r77OXw6CFHsq9d-ugGa_sQoI8LLts7O_CWRL1W6T_AFC_Ei1uHe0RFM3HK7FRmRJ70mj6fJUsw==\" rel=\"nofollow\" target=\"_blank\">beth@bethkeshishian.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjllOWQ2MjAtYzA3Ni00MmIwLWI0NzEtYzExYzg0ODg0NDg4LTEyMDE2NDUtMjAyNi0wOS0wMi1lbg==\/tiny\/Annexon-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following September investor conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. ET in Boston, MA; and, Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 1:35 p.m. ET in New York, NY; and, H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 1:00 p.m. ET in New York, NY. Live webcasts of the presentations can be accessed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annexon to Participate in Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999801","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following September investor conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. ET in Boston, MA; and, Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 1:35 p.m. ET in New York, NY; and, H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 1:00 p.m. ET in New York, NY. Live webcasts of the presentations can be accessed &hellip; Continue reading &quot;Annexon to Participate in Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T13:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annexon to Participate in Upcoming September Investor Conferences\",\"datePublished\":\"2026-09-02T13:05:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/\",\"name\":\"Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\",\"datePublished\":\"2026-09-02T13:05:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annexon-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annexon to Participate in Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk","og_description":"BRISBANE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Annexon, Inc.\u00a0(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following September investor conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. ET in Boston, MA; and, Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 1:35 p.m. ET in New York, NY; and, H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 1:00 p.m. ET in New York, NY. Live webcasts of the presentations can be accessed &hellip; Continue reading \"Annexon to Participate in Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T13:05:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annexon to Participate in Upcoming September Investor Conferences","datePublished":"2026-09-02T13:05:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/","name":"Annexon to Participate in Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=","datePublished":"2026-09-02T13:05:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDA2OSM3ODE0MzUwIzIxOTAwOTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annexon-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annexon to Participate in Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999801"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999801\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}